Editor in Chief's Invitation to Contribute

On behalf of the Editorial Board, it is a pleasure to invite you to submit a manuscript for publication in Biomarkers in Cancer.

We would like to receive articles which describe biomarkers which have been validated by genetic and molecular biology methods. We are particularly interested in biomarkers which can aid our understanding of the etiology, improve the classification, support in the assessment, improve the prevention of, and particularly the targeted treatment of any form of cancer. We invite contributions from a variety of scientific disciplines. We publish original empirical research, reviews, and commentaries.

We provide an efficient, constructive peer review of manuscripts, with an editorial decision in less than 2 weeks for 90% of the papers submitted. Since the journal is open access, dissemination of the work is rapid and is available to anyone with an internet connection, leading to wide exposure for your published article.

Advantages of Publishing

• Visibility: high on-website open access visibility and indexing in Socolar

• Speed: just 21 days average to first editorial decision including two high-quality peer reviews

• Service: accessible professional staff

• Author rewards: submit more than one paper over 365 days and high-priority processing and production and progressively higher levels of article processing fee discount

• Founding author: support this new journal and get high-priority processing and production and a US$1000 article processing fee discount to just US$699.

What Do Your Colleagues Say?

"My experience with Libertas Academica was excellent. The review process was smooth and speedy. After publishing, I received a kind and favorable response from a reader. I have never experienced such a comment after my publications to orthodox journals." -Dr Hiro Koshiyama.  More testimonials...

Read more about preparing your manuscript for submission and watch a video on how to submit it.

Yours sincerely,

Dr Barbara Guinn
Editor-in-Chief
Biomarkers in Cancer